中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2014年
6期
1303-1304
,共2页
张敏%王玉强%高菲菲%谭洪宇%刘屹林%赵亮%王利民%王卫东
張敏%王玉彊%高菲菲%譚洪宇%劉屹林%趙亮%王利民%王衛東
장민%왕옥강%고비비%담홍우%류흘림%조량%왕이민%왕위동
降钙素受体%骨肉瘤%免疫组织化学
降鈣素受體%骨肉瘤%免疫組織化學
강개소수체%골육류%면역조직화학
Calcitonin receptor%Osteosarcoma%Immunohistochemistry
目的 观察降钙素受体(CTR)在骨肉瘤组织的表达,探讨影响骨肉瘤发展、预后的因素.方法 将35例骨肉瘤标本(高分化骨肉瘤组23例和低分化骨肉瘤组12例)设为实验组,10例正常骨组织标本设为对照组,采用链霉菌抗生物素蛋白-过氧化物酶(SP)免疫组织化学方法进行染色,观察CTR的表达.结果 CTR在实验组的阳性表达率为68.6%,CTR在正常骨组织的阳性表达率为30.0%,两组间比较差异有统计学意义(P<0.05);CTR在高分化骨肉瘤的表达率为78.2%,而在低分化骨肉瘤的表达率为33.3%,两者差异有统计学意义(P<0.05);在高分化骨肉瘤中,CTR在男性、女性患者的阳性表达率分别为77.8%和22.2%;在低分化骨肉瘤中,CTR在男性、女性患者的阳性表达率分别为50.0%和50.0%,两组组内不同性别患者分别进行比较差异无统计学意义(P>0.05).结论 骨肉瘤上CTR表达率高于正常骨组织;CTR在高分化组比低分化组表达率高,提示其与肿瘤恶性程度和预后有关.
目的 觀察降鈣素受體(CTR)在骨肉瘤組織的錶達,探討影響骨肉瘤髮展、預後的因素.方法 將35例骨肉瘤標本(高分化骨肉瘤組23例和低分化骨肉瘤組12例)設為實驗組,10例正常骨組織標本設為對照組,採用鏈黴菌抗生物素蛋白-過氧化物酶(SP)免疫組織化學方法進行染色,觀察CTR的錶達.結果 CTR在實驗組的暘性錶達率為68.6%,CTR在正常骨組織的暘性錶達率為30.0%,兩組間比較差異有統計學意義(P<0.05);CTR在高分化骨肉瘤的錶達率為78.2%,而在低分化骨肉瘤的錶達率為33.3%,兩者差異有統計學意義(P<0.05);在高分化骨肉瘤中,CTR在男性、女性患者的暘性錶達率分彆為77.8%和22.2%;在低分化骨肉瘤中,CTR在男性、女性患者的暘性錶達率分彆為50.0%和50.0%,兩組組內不同性彆患者分彆進行比較差異無統計學意義(P>0.05).結論 骨肉瘤上CTR錶達率高于正常骨組織;CTR在高分化組比低分化組錶達率高,提示其與腫瘤噁性程度和預後有關.
목적 관찰강개소수체(CTR)재골육류조직적표체,탐토영향골육류발전、예후적인소.방법 장35례골육류표본(고분화골육류조23례화저분화골육류조12례)설위실험조,10례정상골조직표본설위대조조,채용련매균항생물소단백-과양화물매(SP)면역조직화학방법진행염색,관찰CTR적표체.결과 CTR재실험조적양성표체솔위68.6%,CTR재정상골조직적양성표체솔위30.0%,량조간비교차이유통계학의의(P<0.05);CTR재고분화골육류적표체솔위78.2%,이재저분화골육류적표체솔위33.3%,량자차이유통계학의의(P<0.05);재고분화골육류중,CTR재남성、녀성환자적양성표체솔분별위77.8%화22.2%;재저분화골육류중,CTR재남성、녀성환자적양성표체솔분별위50.0%화50.0%,량조조내불동성별환자분별진행비교차이무통계학의의(P>0.05).결론 골육류상CTR표체솔고우정상골조직;CTR재고분화조비저분화조표체솔고,제시기여종류악성정도화예후유관.
Objective To observe the expression of calcitonin receptor in osteosarcoma cells and explore the factors influencing the development or prognosis of osteosarcoma.Methods Thirty-five cases of osteosarcoma specimens (23 cases in well-differentiated osteosarcoma group,and 12 cases in poorly differentiated osteosarcoma group) were designed as observation group.Ten cases of normal bone tissues served as control group.All the tissues were stained by streptavid-in-peroxidase (SP) method of immunohistochemistry to analyze the expression of calcitonin receptor.Results Positive rate of calcitonin receptor in osteosarcoma cells and normal bone tissues was 68.6% and 30.0% respectively (P < 0.05).The expression rate of calcitonin in well and poorly differentiated osteosarcoma cells was 78.2% (female:22.2%,and male:77.8%) and 33.3% (female:50.0%,and male:50.0%) respectively (P < 0.05).There was no statistically significant difference between two genders in different groups (P > 0.05).Conclusion Positive rate of calcitonin receptor in osteosarcoma cells is higher than in normal bone tissues.What's more,the expression rate of calcitonin in well-differentiated osteosarcoma cells is higher than in poorly differentiated osteosarcoma cells.Calcitonin receptor may be related to grade malignancy and prognosis of osteosarcoma.